ArticleJournal of pediatric surgery2025
Impact of Early Plasma Resuscitation in Pediatric Severe Traumatic Brain Injury.
Article in Journal of pediatric surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Blood Product Transfusion and Coagulopathy in Children with Traumatic Brain Injury: A Narrative Review.Children (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundTraumatic Brain Injury (TBI) is the leading cause of traumatic pediatric mortality. This study examined the safety of early plasma administration in children with severe TBI.
methodsA retrospective cohort study using data from a Level 1 pediatric trauma center from 2016 to 2023 was conducted. Children <18 years old with severe TBI (head Abbreviated Injury Scale (AIS) > 2 and requiring ICU admission) who received component plasma within 24 h of injury were included. Isolated asphyxiation and neck trauma were excluded. Subjects who received "early" plasma (≤4 h from injury) were propensity matched for age, sex, admission GCS, shock, ISS, maximum head AIS, and injury mechanism with those who received "delayed" plasma (>4-24 h post-injury). Adjusted logistic regression on the matched cohort assessed the association between plasma timing and 28-day mortality.
resultsOverall, 71 children met inclusion criteria; 31 received early and 40 received delayed plasma. The cohort was mostly male (66.2%) and injured via blunt mechanism (83.1%), with median(IQR) age 4(1-11) years, ISS 30(26-38), head AIS 5(4-5), and 28-day mortality rate of 62.0%. Among 31 propensity-matched pairs, there was no significant association between plasma timing and adjusted odds of 28-day mortality (Odds Ratio of early plasma 1.75 (95% CI: 0.42-7.31), p = 0.443), no transfusion reaction, and no increase in adverse events.
conclusionsIn this study of children with severe TBI, there were no apparent safety concerns with the receipt of early plasma compared to delayed plasma. Overall mortality was high, demonstrating need for additional therapies for this vulnerable population. TYPE OF STUDY: Retrospective cohort study. LEVEL OF EVIDENCE: Level III.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.